Microbiome analysis reveals the inducing effect of Pseudomonas on prostatic hyperplasia via activating NF-κB signalling
Jiaren Li,Youyou Li,Liang Zhou,Hongming Li,Tengfei Wan,Jin Tang,Lei Zhou,Hui Xie,Long Wang,Jiaren LiYouyou LiLiang ZhouHongming LiTengfei WanJin TangLei ZhouHui XieLong Wanga Department of Urology,The Third Xiangya Hospital,Central South University,Changsha,Hunan,Chinab Movement System Injury and Repair Research Center,Xiangya Hospital,Central South University,Changsha,Hunan,China
DOI: https://doi.org/10.1080/21505594.2024.2313410
IF: 5.428
2024-02-21
Virulence
Abstract:Benign prostatic hyperplasia (BPH) is a prevalent disease among middle-aged and elderly males, but its pathogenesis remains unclear. Dysbiosis of the microbiome is increasingly recognized as a significant factor in various human diseases. Prostate tissue also contains a unique microbiome, and its dysbiosis has been proposed to contribute to prostate diseases. Here, we obtained prostate tissues and preoperative catheterized urine from 24 BPH individuals, and 8 normal prostate samples as controls, which followed strict aseptic measures. Using metagenomic next-generation sequencing (mNGS), we found the disparities in the microbiome composition between normal and BPH tissues, with Pseudomonas significantly enriched in BPH tissues, as confirmed by fluorescence in situ hybridization (FISH). Additionally, we showed that the prostate microbiome differed from the urine microbiome. In vitro experiments revealed that lipopolysaccharide (LPS) of Pseudomonas activated NF-κB signalling, leading to inflammation, proliferation, and EMT processes, while inhibiting apoptosis in prostatic cells. Overall, our research determines the presence of microbiome dysbiosis in BPH, and suggests that Pseudomonas , as the dominant microflora, may promote the progression of BPH through LPS activation of NF-κB signalling.
microbiology,immunology,infectious diseases